Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Liu, Kai-Yan  [Clear All Filters]
Journal Article
Tang, F.-F., Huang, X.-J., Zhang, X.-H., Chen, H., Chen, Y.-H., Han, W., Chen, Y., Wang, F.-R., Wang, Y., Wang, J.-Z., et al. (2016). Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.Leuk Res47, 8-15.
Xue, Y.-J., Cheng, Y.-F., Lu, A.-D., Wang, Y., Zuo, Y.-X., Yan, C.-H., Wu, J., Sun, Y.-Q., Suo, P., Chen, Y.-H., et al. (2018). Allogeneic hematopoietic stem cell transplantation, especially haploidentical HSCT, may improve long-term survival for high-risk pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era.Biol Blood Marrow Transplant.
Xu, L.-P., Xu, Z.-L., Zhang, X.-H., Chen, H., Chen, Y.-H., Han, W., Chen, Y., Wang, F.-R., Wang, J.-Z., Wang, Y., et al. (2016). Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.Biol Blood Marrow Transplant.
Shi, M.-M., Kong, Y., Song, Y., Sun, Y.-Q., Wang, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., and Huang, X.-J. (2016). Atorvastatin enhances endothelial cell function in post transplant poor graft function.Blood.
Ma, R., Huang, X.-J., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Yan, C.-H., Han, W., Wang, F.-R., Chen, Y.-H., Chen, H., et al. (2019). Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies.Biol Blood Marrow Transplant.
Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 19.Biol Blood Marrow Transplant.
Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (.Biol Blood Marrow Transplant.
Han, T.-T., Xu, L.-P., Liu, D.-H., Liu, K.-Y., Fu, H.-X., Zhao, X.-Y., Zhao, X.-S., and Huang, X.-J. (2013). Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation.Am J Hematol.
Zhao, X.-Y., Yu, X.-X., Xu, Z.-L., Cao, X.-H., Huo, M.-R., Zhao, X.-S., Chang, Y.-J., Wang, Y., Zhang, X.-H., Xu, L.-P., et al. (2019). Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.Blood Adv3, 4312-4325.
Zhang, J.-M., Xu, Y., Gale, R.P., Wu, L.-X., Zhang, J., Feng, Y.-H., Qin, Y.-Z., Jiang, H., Jiang, Q., Jiang, B., et al. (2020). DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia.Br J Haematol.
Chang, Y.-J., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., Yan, C.-H., et al. (2018). Effects of low-dose glucocorticoid prophylaxis on chronic GVHD and GVHD-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial.Biol Blood Marrow Transplant.
Chen, Y., Huang, X.-J., Wang, Y., Liu, K.-Y., Chen, H., Chen, Y.-H., Zhang, X.-H., Wang, F.-R., Han, W., Wang, J.-Z., et al. (2015). Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors.Transfusion.
Zhao, X.-Y., Pei, X.-Y., Chang, Y.-J., Yu, X.-X., Xu, L.-P., Wang, Y., Zhang, X.-H., Liu, K.-Y., and Huang, X.-J. (2019). First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.Clin Infect Dis.
Zhang, Y.-Y., Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., et al. (2019). FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.Bone Marrow Transplant.
Zeng, Q.-Z., Zhang, Y.-Y., Wu, Y.-J., Zhang, Z.-Y., Zhang, J.-N., Fu, H.-X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Mo, X.-D., et al. (2020). Frequency, risk factors and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Zhang, X.-H., Feng, F.-E., Han, W., Wang, F.-R., Wang, J.-Z., Wang, Y., Chen, Y., Fu, H.-X., Mo, X.-D., Zhang, Y.-Y., et al. (2016). High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation.Thromb Res144, 6-11.
Yan, C.-H., Wang, Y., Mo, X.-D., Sun, Y.-Q., Wang, F.-R., Fu, H.-X., Chen, Y., Han, T.-T., Kong, J., Cheng, Y.-F., et al. (2018). Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.Clin Infect Dis67, S162-S173.
Wang, X.-L., Han, W., Zhao, P., Liu, X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Zhang, Y.-Y., Mo, X.-D., Wang, Y., et al. (2019). Incidence, Risk Factors, Outcomes and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant.
Kong, Y., Song, Y., Hu, Y., Shi, M.-M., Wang, Y.-T., Wang, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., Deng, H.-K., et al. (2016). Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.Oncotarget.
Lv, M., Zhao, X.-S., Hu, Y., Chang, Y.-J., Zhao, X.-Y., Kong, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., and Huang, X.-J. (2014). Monocytic and Promyelocytic Myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.Am J Hematol.
Huo, M.-R., Xu, Y.-J., Zhai, S.-Z., Lv, M., Wang, Y., Cao, L.-Q., Xu, L.-P., Zhang, X.-H., Chen, H., Chen, Y.-H., et al. (2018). Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.Hum Immunol.
Bai, L., Cheng, Y.-F., Lu, A.-D., Suo, P., Wang, Y., Zuo, Y.-X., Yan, C.-H., Wu, J., Jia, Y.-P., Sun, Y.-Q., et al. (2020). Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.Leuk Res91, 106333.
Wang, X.-Y., Fan, Q.-Z., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., et al. (2019). The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.Cytometry B Clin Cytom.
Tian, D.-M., Wang, Y., Zhang, X.-H., Liu, K.-Y., Huang, X.-J., and Chang, Y.-J. (2016). Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation.Plos One11, e0156777.
Zhang, X.-H., Wang, G.-X., Zhu, H.-H., Liu, Y.-R., Xu, L.-P., Han, W., Chen, H., Chen, Y.-H., Wang, F.-R., Wang, J.-Z., et al. (2015). Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.Ann Hematol.

Pages